Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 52Carcinoma, Renal Cell 25Liver Neoplasms 23Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 16Kidney Neoplasms 11Leukemia, Myeloid, Acute 9Melanoma 8Glioblastoma 8Sarcoma 7Prostatic Neoplasms 7Neoplasm Metastasis 7Brain Neoplasms 7Thyroid Neoplasms 6Ovarian Neoplasms 6Lung Neoplasms 6Pancreatic Neoplasms 5Gliosarcoma 5Urinary Bladder Neoplasms 4Recurrence 4Leukemia, Myelomonocytic, Chronic 4Leukemia 4Carcinoma 4Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Multiple Myeloma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leiomyosarcoma 3

Interventions

Tretinoin 5Methotrexate 5Tacrolimus 4Arsenic Trioxide 4fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Busulfan 3Mycophenolic Acid 2Mercaptopurine 2Idarubicin 2Gemtuzumab 2Filgrastim 2Cytarabine 2Cyclophosphamide 2Antilymphocyte Serum 2thymoglobulin 1entinostat 1Whole-Body Irradiation 1Vorinostat 1Sorafenib 1Sirolimus 1Granulocyte Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Daunorubicin 1Clofarabine 1Bortezomib 1Biopsy 1Azacitidine 1Alemtuzumab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Promyelocytic, Acute × Sorafenib × Clear all
NCT01253070 2022-08-04

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡